The patented Safe-2-Dose™ Integrated Dosing Container is the next generation Infants elixir dispenser providing enhanced medication dosing accuracy and user convenience. The caregiver need only disabl
At Asepsis, our goal is to seek global collaboration for the integration of our proprietary delivery enhancements to existing or prospective marketed medicinal solutions, for line extensions and therapeutic differentiation.
Our portfolio focuses on enhancing medication efficacy and safety by providing higher precision adherence to established optimal clinical dosing, while in parallel reducing user preparation and administration sequences.
We are always looking to expand our existing product portfolios in existing or unoccupied markets through:
♦ IP acquisition
♦ Licensing arrangements
♦ Development collaborations
♦ Exclusive territory representation
♦ Patent and/or product exclusivity
Asepsis Medical Technologies LLC
1584 Independence Blvd.
Sarasota, FL 34234
Tel: +1-941-360-0029
Fax: +1-941-360-0035
[email protected]
Latest News
Asepsis Announces The Grant Of Mexico Patent No. 384,129
Asepsis Medical Technologies® is proud to introduce the latest addition to the Calibrated Drug Delivery™ (CCD) platform, the Multi-Dose Safe-2-Dose® syringe. The Multi-Dose Safe-2-
Asepsis Announces the Grant of Canadian Patent No. 3,006,218
Asepsis Medical Technologies® is proud to announce their latest Canadian Patent Grant 3,006,218 of August 24, 2021 – for the multi-dose oral Dose-2-Weight Syringe®. The Dose-2-Weight Sy
Asepsis announces the US Patent Grant 11,058,606
Asepsis Medical Technologies announces the USPTO issuance of Patent Application Number 11,058,606 for its Safe-T-Fuse™ drug infusion system. The Safe-T-Fuse™ is an industry unique infusion contai
Asepsis Announces the Grant of Mexico Patent MX/a/2017/012034
The Safe-T-Syringe® is designed to deliver the highest standard of patient care via syringe. Its medication calibrated indicia provide enhanced accuracy, convenience and safety through-out preparation
Asepsis Announces the Grant of U.S. Patent 10,857,299
Asepsis Medical Technologies® is proud to introduce the latest addition to the Calibrated Drug Delivery™ (CCD) platform, the Multi-Dose Safe-2-Dose® syringe. The Multi-Dose Safe-2-Dose® syringe provid
Asepsis Announces the U.S. Patent Grant No. 10,625,026
Asepsis Medical Technologies announces the U.S. Patent Grant for the Momenta-Dose™ forcé actuated injection device. The Momenta Dose™ is designed to administer rapid small volume subcutaneous or intra